Synlogic logo

SynlogicNASDAQ: SYBX

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

30 September 2015

Next earnings report:

19 March 2025

Last dividends:

N/A

Next dividends:

N/A
$16.90 M
-62%vs. 3y high
23%vs. sector
-vs. 3y high
-vs. sector
-25%vs. 3y high
45%vs. sector
-vs. 3y high
-vs. sector

Price

regular market | Wed, 20 Nov 2024 14:30:00 GMT
$1.45+$0.09(+6.25%)

Dividend

No data over the past 3 years

Analysts recommendations

Institutional Ownership

SYBX Latest News

Synlogic Reports Third Quarter 2024 Financial Results
globenewswire.com12 November 2024 Sentiment: POSITIVE

WINCHESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported financial results for the third quarter 2024 and provided a corporate update.

Synlogic, Inc. (SYBX) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research19 March 2024 Sentiment: NEGATIVE

Synlogic, Inc. (SYBX) came out with a quarterly loss of $1.71 per share versus the Zacks Consensus Estimate of a loss of $1.11. This compares to loss of $3.60 per share a year ago.

Why Is Synlogic (SYBX) Stock Down 55% Today?
InvestorPlace09 February 2024 Sentiment: NEGATIVE

Synlogic (NASDAQ: SYBX ) stock is falling on Friday after the clinical-stage biopharmaceutical company announced the discontinuation of its Synpheny-3 clinical trial. According to a press release from Synlogic, this decision comes after an internal review of the clinical trial's progress.

Why Is Synlogic (SYBX) Stock Down 6% Today?
InvestorPlace28 September 2023 Sentiment: NEGATIVE

Synlogic (NASDAQ: SYBX ) stock is sliding lower on Thursday after the biopharmaceutical company announced a reverse split for its shares. According to a press release from Synlogic, the company enacted a reverse stock split after markets closed yesterday.

Synlogic to Present at the Jefferies Global Healthcare Conference
GlobeNewsWire23 May 2023 Sentiment: POSITIVE

CAMBRIDGE, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that Aoife Brennan, M.B. Ch.B., President and Chief Executive Officer, will present at the Jefferies Global Healthcare Conference being held in New York, NY, June 7-9, 2023.

Synlogic, Inc. (SYBX) Reports Q4 Loss, Misses Revenue Estimates
Zacks Investment Research29 March 2023 Sentiment: NEGATIVE

Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 7.69% and 73.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

What type of business is Synlogic?

Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. for the research and pre-clinical development of a synthetic biotic medicine for the treatment of inflammatory bowel disease; and Ginkgo Bioworks, Inc. Synlogic, Inc. is based in Cambridge, Massachusetts.

What sector is Synlogic in?

Synlogic is in the Healthcare sector

What industry is Synlogic in?

Synlogic is in the Biotechnology industry

What country is Synlogic from?

Synlogic is headquartered in United States

When did Synlogic go public?

Synlogic initial public offering (IPO) was on 30 September 2015

What is Synlogic website?

https://www.synlogictx.com

Is Synlogic in the S&P 500?

No, Synlogic is not included in the S&P 500 index

Is Synlogic in the NASDAQ 100?

No, Synlogic is not included in the NASDAQ 100 index

Is Synlogic in the Dow Jones?

No, Synlogic is not included in the Dow Jones index

When was Synlogic the previous earnings report?

No data

When does Synlogic earnings report?

The next expected earnings date for Synlogic is 19 March 2025